Physician profile
Kaming Li
NPI 1295993913
$2,058.50
in general payments reported to CMS, 2019-2025
10 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $258 · 2021: $121 · 2022: $284 · 2023: $676 · 2024: $274 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,226.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $844.62 | 2019-2025 | |
| Abbvie INC. | $391.88 | 2023-2025 | |
| Mentor Worldwide LLC | $251.62 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Sientra, INC. | $189.24 | 2020-2021 | |
| Allergan, INC. | $184.97 | 2019-2022 | |
| Revance Therapeutics, INC. | $102.44 | 2025 | Daxxify |
| Galderma Laboratories, L.P. | $75.99 | 2019-2024 | Dysport |
| Novo Nordisk INC | $13.98 | 2023 | Wegovy |
| Apyx Medical Corporation | $3.76 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaming Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.